Low molecular weight heparin or semuloparin should not be...

Low molecular weight heparin or semuloparin should not be recommended for thromboprophylaxis in ambulatory solid cancer patients undergoing chemotherapy

Oo, Thein H.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
130
Language:
english
Journal:
Thrombosis Research
DOI:
10.1016/j.thromres.2012.07.026
Date:
November, 2012
File:
PDF, 113 KB
english, 2012
Conversion to is in progress
Conversion to is failed